NFXF Webinar for Professionals

Are you a professional seeking Fragile X funding? Please join us for an informational webinar about funding opportunities on April 10th at 12pm ET with the Program Manager for the Peer Reviewed Medical Research Program (PRMRP).

Thanks to the efforts of NFXF Advocates, Fragile X is once again included as an eligible research topic for Fiscal Year 24 (FY24). All FMR1-associated conditions and disorders (FXS, FXPOI, FXTAS) are included under the term “Fragile X”.

Register at: NFXF Webinar – Information on the PRMRP FY 24 Funding Opportunities (fragilex.org)

Additional Information about PRMRP

Over $32M has been awarded for Fragile X-associated conditions and disorders research since 2010, when Fragile X was first included as an eligible condition for funding from the Congressionally Directed Medical Research Program (CDMPR) Peer Reviewed Medical Research Program (PRMRP), including the recent award of up to $11.4 M for a clinical trial for individuals living with Fragile X-associated Tremor/Ataxia syndrome (FXTAS). Thanks to the efforts of the NFXF advocates, Fragile X, which includes all FMR1-associated conditions and disorders, is once again included as an eligible topic area for Fiscal Year 24 (FY24). The PRMRP is within the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP) – a global funding organization that fosters novel approaches to congressionally targeted biomedical research areas. CDMRP receives annual appropriations that are disease or condition-specific. Congress appropriated $370M in funding For the FY24 budget within the PRMRP.

If you have additional questions, feel free to email us at contact@fragilex.org.

The webinar will be recorded and available to all registrants.